• CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources

     

  • 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsGAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    Rescheduled, so you won't miss a thing! Find out what to do next!

    April 20-24, 2021, Honolulu, Hawaii

    More Information

  • W A N T E D   G A P N A   L E A D E R S!
    Call for Nominations! (EXTENDED DEADLINE)

    Have you ever considered stepping forward, accepting the challenge and volunteering for a position on the 2020-21 National Board of Directors? Register online NOW by March 31, 2020!

    Step Up - NOW is the Time! Register Here>

  • AwardCall for Excellence Award Nominations

    The awards are: Emerging Chapter Award, Established Chapter Excellence Award, Special Interest Group Excellence Award, Excellence in Clinical Practice Award, Excellence in Community Service Award, Excellence in Education Award, Excellence in Leadership Award, and Excellence in Research Award.

    The nominations are tallied in July and the winners are announced every year during the Awards Celebration at the GAPNA Annual Conference.

    Now is the time to nominate a colleague or yourself - DEADLINE is June 1, 2020.

    Get started... nominate today!

Studies Link Adverse Drug Interactions to Elevated Risk for Hospitalization Among the Elderly

A review of 17 studies that assessed specific drug interactions in elderly patients found that 16 of the studies reported an elevated risk for hospitalization in older adults associated with drug interactions.

These interactions included angiotensin-converting enzyme (ACE) inhibitors and potassium-sparing diuretics; ACE inhibitors or angiotensin receptor blockers and sulfamethoxazole/trimethoprim (SMX/TMP); benzodiapines or zolpidem and other medications; calcium channel blockers and macrolide antibiotics; digoxin and macrolide antibiotics; lithium and loop diuretics or ACE inhibitors; phenytoin and SMX/TMP; sulfonylureas and antimicrobial agents; theophylline and ciprofloxacin; and warfarin and antimicrobial agents or non-steroidal anti-inflammatory drugs.

The researchers concluded that when the elderly receive drug therapy, it should be absolutely necessary for the achievement of well-defined goals. They also recommend that an evidence-based, high-priority list of drug interactions in the elderly be developed and maintained.

For more info, see Hines, L.E. et al. (2011). Potentially harmful drug-drug interactions in the elderly: A review. American Journal of Geriatric Pharmacotherapy, 9, 364-377.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: